Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

158 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[High-dose chemoradiotherapy combined with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) followed by autologous peripheral blood stem cell transplantation (PBSCT) in a case of refractory acute myelogenous leukemia (AML)].
Tanosaki R, Okamoto S, Takahashi S, Inoue T, Kikuno K, Aoki Y, Takada M, Irie S, Shimane M, Tojo A, et al. Tanosaki R, et al. Rinsho Ketsueki. 1993 Aug;34(8):946-51. Rinsho Ketsueki. 1993. PMID: 8105115 Japanese.
Response-oriented preemptive therapy against cytomegalovirus disease with low-dose ganciclovir: a prospective evaluation.
Kanda Y, Mineishi S, Saito T, Saito A, Ohnishi M, Niiya H, Chizuka A, Nakai K, Takeuchi T, Matsubara H, Makimoto A, Tanosaki R, Kunitoh H, Tobinai K, Takaue Y. Kanda Y, et al. Among authors: tanosaki r. Transplantation. 2002 Feb 27;73(4):568-72. doi: 10.1097/00007890-200202270-00015. Transplantation. 2002. PMID: 11889432 Clinical Trial.
Therapeutic potential of a reduced-intensity preparative regimen for allogeneic transplantation with cladribine, busulfan, and antithymocyte globulin against advanced/refractory acute leukemia/lymphoma.
Saito T, Kanda Y, Kami M, Kato K, Shoji N, Kanai S, Ohnishi T, Kawano Y, Nakai K, Ogasawara T, Matsubara H, Makimoto A, Tanosaki R, Tobinai K, Wakasugi H, Takaue Y, Mineishi S. Saito T, et al. Among authors: tanosaki r. Clin Cancer Res. 2002 Apr;8(4):1014-20. Clin Cancer Res. 2002. PMID: 11948108 Clinical Trial.
High complete response rate after allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in advanced malignant lymphoma.
Tanimoto TE, Kusumi E, Hamaki T, Yuji K, Ueyama J, Miyakoshi S, Morinaga S, Kami M, Kanda Y, Ando T, Yoshihara S, Masuo S, Kim SW, Nakai K, Tobinai K, Tanosaki R, Mineishi S, Takaue Y, Muto Y. Tanimoto TE, et al. Among authors: tanosaki r. Bone Marrow Transplant. 2003 Jul;32(2):131-7. doi: 10.1038/sj.bmt.1704118. Bone Marrow Transplant. 2003. PMID: 12838276 Clinical Trial.
Induction of graft-versus-autoimmune (GVA) disease effect against refractory psoriasis by complete donor-type chimerism and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Kojima R, Kami M, Kim SW, Murashige N, Kishi Y, Hori A, Imataki O, Hamaki T, Sakiyama M, Masuo S, Fujisawa Y, Makimoto A, Heike Y, Tanosaki R, Takaue Y. Kojima R, et al. Among authors: tanosaki r. Bone Marrow Transplant. 2003 Aug;32(4):439-42. doi: 10.1038/sj.bmt.1704146. Bone Marrow Transplant. 2003. PMID: 12900783
158 results